Quest Diagnostics Incorporated (DGX)

85.75
NYSE
Prev Close 85.75
Day Low/High 0.00 / 0.00
52 Wk Low/High 78.95 / 116.49
Exchange NYSE
Shares Outstanding 134.58B
Market Cap 11.54B
Div & Yield N.A. (N.A)

Latest News

Quest Diagnostics Becomes #151 Most Shorted S&P 500 Component, Replacing American International Group

Quest Diagnostics Becomes #151 Most Shorted S&P 500 Component, Replacing American International Group

The most recent short interest data has been released for the 03/29/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Massachusetts Governor Baker Visits State Of The Art Quest Diagnostics Marlborough Laboratory

Massachusetts Governor Baker Visits State Of The Art Quest Diagnostics Marlborough Laboratory

MARLBOROUGH, Mass., April 1, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, hosted Massachusetts Governor Charlie Baker at its state-of-the-art clinical testing laboratory...

Quest Diagnostics To Present New Insights From Genetic Testing At The 2019 Annual American College Of Medical Genetics And Genomics Annual Clinical Genetics Meeting

Quest Diagnostics To Present New Insights From Genetic Testing At The 2019 Annual American College Of Medical Genetics And Genomics Annual Clinical Genetics Meeting

Eight presentations highlight Quest's Advanced Diagnostics testing and research insights into hereditary genetics

Quest Diagnostics Prices $500 Million Of Senior Notes

Quest Diagnostics Prices $500 Million Of Senior Notes

SECAUCUS, N.J.

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J.

Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019

Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019

- Fourth quarter revenues of $1.84 billion, down 1.4% versus 2017

Quest Diagnostics Expected to Earn $1.37 a Share

Quest Diagnostics Expected to Earn $1.37 a Share

Revenue expected to fall 3% to $1.9 billion for medical services provider.

Quest Diagnostics Becomes #157 Most Shorted S&P 500 Component, Replacing Cimarex Energy

Quest Diagnostics Becomes #157 Most Shorted S&P 500 Component, Replacing Cimarex Energy

The most recent short interest data has been released for the 01/31/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Quest Diagnostics Completes Acquisition Of Laboratory Services Business Of Boyce & Bynum Pathology Laboratories

Quest Diagnostics Completes Acquisition Of Laboratory Services Business Of Boyce & Bynum Pathology Laboratories

Transaction expands access to diagnostic innovations in clinical and pathology services for patients, physicians and hospitals throughout Missouri and surrounding Midwestern states

More Adults Know Their Multidigit Wi-Fi Password Than Vital Health Information, Including Their Single-Letter Blood Type

More Adults Know Their Multidigit Wi-Fi Password Than Vital Health Information, Including Their Single-Letter Blood Type

Nearly Six in Ten Recognize Access to Health Vitals is Important in an Emergency, Yet Nearly 30 Percent Keep Lab Results in a File Cabinet at Home

Quest Diagnostics Becomes #212 Most Shorted S&P 500 Component, Replacing International Paper

Quest Diagnostics Becomes #212 Most Shorted S&P 500 Component, Replacing International Paper

The most recent short interest data has been released for the 12/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Aetna And Ascension Join Five Other Leading Health Care Companies In Blockchain-Driven Effort To Address Health Care Provider Data Issues

Aetna And Ascension Join Five Other Leading Health Care Companies In Blockchain-Driven Effort To Address Health Care Provider Data Issues

Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health care provider demographic data.

Quest Diagnostics To Discuss Strategic Growth Drivers And Financial Outlook At 2018 Investor Day

Quest Diagnostics To Discuss Strategic Growth Drivers And Financial Outlook At 2018 Investor Day

-- Provides outlook for 2019-2022, extending the company's targeted 3-5% revenue compound annual growth rate (CAGR) and updating its adjusted earnings goal to a 4-6% CAGR

Quest Diagnostics To Build Flagship Laboratory At Visionary Campus In Clifton, New Jersey To Empower Better Health For Patients In Seven States

Quest Diagnostics To Build Flagship Laboratory At Visionary Campus In Clifton, New Jersey To Empower Better Health For Patients In Seven States

New lab to be the company's largest in country with more than 1,100 employees, featuring innovative design, automation and expanded capacity

Quest Diagnostics To Acquire The Laboratory Services Business Of Boyce And Bynum Pathology Laboratories, Expanding Diagnostic Innovation In The Midwest

Quest Diagnostics To Acquire The Laboratory Services Business Of Boyce And Bynum Pathology Laboratories, Expanding Diagnostic Innovation In The Midwest

Transaction aims to provide a broader range of clinical and pathology diagnostic services to patients, hospitals and physicians throughout Missouri and surrounding Midwestern states

TheStreet Quant Rating: B- (Buy)